Colorectal cancer cells resistant to oxaliplatin are more sensitive to TRAIL, and the mechanism is that the DR4 level is up-regulated due to increased palmitoylation of DR4 and increased metastasis to lipid rafts [178]. Here, TNFRSF10A is linked to colorectal cancer.